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http://dxObjective: The best adjunct for cerebral protection during aortic arch reconstruction remains controversial. Retro-
grade cerebral perfusion (RCP) as an adjunct to profound hypothermic circulatory arrest (PHCA) extends the toler-
able period of brain ischemia byflushing emboli and air from the cerebral circulationwhilemaintaining hypothermia.
We examined our experiencewith RCP to determine its efficacy in patients undergoing complex arch reconstruction.
Methods:We retrospectively evaluated 879 patients undergoing arch reconstruction using RCP from July 1997
to March 2013. Perioperative risk factors were analyzed as predictors of neurologic injury and mortality. Sur-
vival for the type of arch reconstruction and for the interval of PHCAwas calculated.
Results: Of the 879 patients, 671 underwent hemiarch and 208 total arch replacement. The mean age was 65 
13.3 years, and 61.6% were men. The total arch patients had longer mean periods of PHCA (39 vs 21 minutes,
P<.001) and RCP (37 vs 19 minutes, P<.001). However, the incidence of transient neurologic dysfunction
(3.0% vs 2.4%, P<.813) and permanent neurologic dysfunction (1.3% vs 1.9%, P<.519) was similar for
both techniques. Mortality was greater in the hemiarch group (4.8% vs 0.5%, P< .003). Patients requiring
>40 minutes of PHCA had outcomes similar to those requiring less. The 1-, 5-, and 10-year survival was similar,
regardless of the procedure performed or interval of PHCA.
Conclusions: RCP is a safe and effective adjunct for cerebral protection during arch surgery. Patients requiring
more extensive arch reconstruction are not at greater risk of permanent neurologic dysfunction or perioperative
mortality. (J Thorac Cardiovasc Surg 2014;148:2927-35)A
C
DDeep hypothermic circulatory arrest (DHCA) has been a
mainstay of cerebral protection for aortic arch reconstruc-
tion for nearly 4 decades. Since the introduction of this tech-
nique into the adult population by Griepp and colleagues,1
profound hypothermia has been the most commonly used
method for prevention of permanent and temporary neuro-
logic dysfunction in patients requiring surgery for arch
pathologic entities. As the primary brain protection strategy,
however, DHCA has its limitations. Svensson and col-
leagues2 demonstrated that the risk of permanent cerebro-
vascular accident (CVA) increased after 45 minutes of
hypothermic arrest and the risk of death increased dramat-
ically when DHCA was needed for periods>60 minutes.3
A more recent examination of straight deep hypothermia
confirmed the limitations of this technique during longer
periods of circulatory arrest and also revealed a substantiale Department of Cardiothoracic Surgery,Weill Cornell Medical College, New
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The Journal of Thoracic and Carpercentage of these permanent neurologic injuries were sec-
ondary to hypoperfusion rather than embolic events.4
To reduce the incidence of CVA, transient neurologic
dysfunction (TND), and death, adjuncts such as barbiturates,
steroids, and topical cooling have been used in conjunction
with profound hypothermia to possibly extend the tolerable
period of circulatory arrest.5,6 The 2 most commonly used
adjuncts, however, have been retrograde cerebral perfusion
(RCP) and antegrade cerebral perfusion (ACP). RCP is
attractive in its simplicity. It flushes atherosclerotic debris
and air out of the cerebral circulation, maintains brain
hypothermia while the circulation is arrested, and
avoids great vessel manipulation with its potential for
atherosclerotic emboli.7 Its detractors have cited animal
studies showing negligible brain capillary blood flow during
RCP in both a primate and a porcine model.8,9 ACP clearly
provides nutritive brain blood flow and in some studies has
proved beneficial when the period of circulatory arrest
exceeds 45 minutes.10,11 The continuation of brain
perfusion during ACP has also encouraged investigators to
use lesser degrees of hypothermia in the hopes of
shortening the length of surgery, reducing the systemic
inflammatory response, and minimizing the incidence of
clinically significant bleeding.12,13 Currently, ACP is the
most commonly used adjunct for brain protection during
arch reconstruction. However, single-center randomized tri-
als and large meta-analyses have failed to show an advantage
of ACP versus RCP.11,14diovascular Surgery c Volume 148, Number 6 2927
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
CPB ¼ cardiopulmonary bypass
CVA ¼ cerebrovascular accident
DHCA ¼ deep hypothermic circulatory arrest
PND ¼ permanent neurologic deficit
RCP ¼ retrograde cerebral perfusion
TND ¼ transient neurologic dysfunction
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DDuring the past 15 years, we have continued to use RCP
as an adjunct to PHCA during aortic arch reconstruction.
We wished to examine whether patients undergoing com-
plex total arch reconstruction were at greater risk of neuro-
logic injury and mortality compared with patients whowere
undergoing hemiarch reconstruction and requiring shorter
periods of circulatory arrest. We also sought to determine
whether previously defined time restrictions on tolerable
circulatory arrest were still valid when RCP was used as
an adjunct.METHODS
Patients
A retrospective review of the cardiothoracic surgery department’s aortic
surgery database was conducted to identify patients undergoing surgery
requiring PHCA and RCP from July 1997 to March 2013. The institutional
review board approved the study and waived the need for individual patient
consent.
All patients undergoing aortic arch reconstruction were examined,
including those undergoing surgery for acute aortic pathologic features.
Of the 921 patients included in the database, 25 required the assistance
of PHCA for tumor removal (eg, renal cell carcinoma with caval extension,
T4mediastinal tumors). An additional 17 patients required the assistance of
PHCA for either congenital conditions or cerebral aneurysm clipping. Both
of these subsets of patients were excluded, leaving 879 patients available
for statistical analysis. The patients were followed up until the point of their
last computed tomography scan or death.
Anesthesia and Surgical Procedures
General anesthesia was induced with intravenous midazolam hydro-
chloride and sodium pentothal or propofol, followed by fentanyl citrate bo-
luses. Paralysis was maintained using vecuronium bromide. All patients
received invasive hemodynamic monitoring with an arterial line and right
heart catheter. For patients with arch pathology emanating from the
ascending aorta, the procedures were performed through a median sternot-
omy (n¼ 839). For patients with arch pathology extending varying lengths
into the descending aorta or thoracoabdominal aorta, surgery was per-
formed through a fifth interspace thoracotomy and extended into the
abdomen as necessary (n ¼ 40). These patients with a concomitant de-
scending aorta or thoracoabdominal aorta also received single lung venti-
lation and spinal drainage catheters.
Before the initiation of cardiopulmonary bypass (CPB), the patients
were given 400 IU/kg of heparin. An activated clotting time>480 seconds
signified adequate anticoagulation. The patients were given a loading dose
of 10 g of aminocaproic acid (Amicar) and a 1 g/h infusion throughout the
case; 10 g was also added to the CPB circuit. Most patients received central
aortic cannulation (n ¼ 626), and 251 received femoral or axillary (n ¼ 2)
cannulation. The flows on CPB were maintained at 2.4 L/min/m2 at2928 The Journal of Thoracic and Cardiovascular Surnormothermia and 1.8 L/min/m2 during periods of cooling. The mean arte-
rial pressure was maintained at 70 to 80 mm Hg at all times, regardless of
the flow or temperature. Near infrared spectroscopy was used to confirm
symmetric cerebral cooling and warming (Somanetics, Corp, Troy,
Mich). The patient’s head was packed in ice once cooling began. The pa-
tients were cooled to 18C for a minimum of 30 minutes (mean, 33.56 
4.9). Three minutes before arresting the circulation, 500 mg of methohex-
ital (Brevital) was administered. The patient was then placed into the Tren-
delenburg position and the circulation arrested.
During PHCA, blood was given through the superior vena cava cannula
at 150 mL/min and 300 mL/min at 14C, keeping the central venous pres-
sure<30 mm Hg. Arch reconstruction was performed with a Hemashield
Dacron graft (Macquet Corp, Oakland, NJ), using 1 of 4 basic techniques:
hemiarch replacement, total arch replacement with great vessel reimplan-
tation as an island, total arch with an elephant trunk, or total arch with great
vessel debranching. All inaccessible suture lines were reinforced circum-
ferentially with interrupted horizontal mattress Teflon felt pledget rein-
forced polypropylene sutures. After arch reconstruction, CPB was
resumed through a prefabricated branched graft off of the main arch graft.
RCP was maintained until full flow on CPB has been re-established. Once
the anastomotic sites were thought to be hemostatic, systemic warming
ensued (mean warming time, 71.7 minutes), keeping a gradient of 10C be-
tween the blood and the patient’s core temperature. CPB was discontinued
at 35C. After protamine administration, the blood products were given as
necessary. The patient was closed and transferred to the intensive care unit.
Demographic data and perioperative complications were collected for
all patients. Perioperative mortality was defined as death occurring within
30 days of surgery or at any time during the initial hospitalization. Perma-
nent neurologic deficits (PNDs) were defined as stroke, coma, or any new
focal neurologic deficit that persisted >48 hours, accompanied by
computed tomography or magnetic resonance imaging findings confirming
a new brain injury. TND was defined as the presence of delirium, agitation,
confusion, seizure, or a focal motor deficit lasting 72 hours without evi-
dence of new cerebral injury on either a computed tomography scan or
magnetic resonance imaging study.
Postoperative renal insufficiency was defined as doubling of the serum
creatinine or the need for hemodialysis. Pulmonary complications were
defined as ventilator support>48 hours, reintubation, adult respiratory
distress syndrome, pneumonia, or the need for tracheostomy.STATISTICAL ANALYSIS AND DATA
MANAGEMENT
All the data collected from July 1997 toMarch 2013 were
stored using Microsoft Access (2010) software (Microsoft,
Redmond, Wash). A total of 879 patients were included in
the analysis.
The chi-square test was used to compare the categorical
variables. Univariate associations were tested by Pearson
correlation coefficients for continuous variables. Factors
with a P value <.2 in linear univariate analysis were
included in the multivariate analysis. Logistic and Cox
regression analysis were used as methods of multivariate
analysis to establish the predictive capacity of different
pre- and intraoperative factors on postoperative complica-
tions and mortality.
The Kaplan-Meier estimator with and without an adja-
cent log-rank test was used to assess the long-term survival
and to compare the survival distributions.
All tests were 2-tailed. The data were analyzed using
IBM SPSS, version 22.0 (IBM, Armonk, NY).gery c December 2014
TABLE 1. Patient demographics
Demographic data Hemiarch (n ¼ 671) Total arch (n ¼ 208) P value
Age>65 y 406 (60.5) 136 (65.4) .221
Male sex 421 (62.7) 118 (56.7) .122
Mean aortic aneurysm diameter (cm) 5.86  1.36 6.6  1.46 .0001
Previous CVA 101 (15.1) 37 (17.8) .383
Previous MI 125 (18.6) 23 (11.1) .011
HTN 645 (96.1) 199 (95.7) .839
COPD 145 (21.6) 45 (21.6) .99
Preoperative dialysis 15 (2.2) 4 (1.9) .79
Connective tissue disease 17 (2.5) 13 (6.3) .015
Previous OHS 148 (22.1) 58 (27.9) .092
Status of procedure (urgent or emergency) 346 (51.6) 74 (35.6) .0001
Acute type A dissection 198 (25.0) 28 (13.5) .001
Aortic rupture 46 (6.9) 16 (7.7) .645
Data presented as n (%) or mean  standard deviation. CVA, Cerebrovascular accident; MI, myocardial infarction; HTN, hypertension; COPD, chronic obstructive pulmonary
disease; OHS, open heart surgery.
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DRESULTS
The patients were separated into 2 groups for analysis ac-
cording to the complexity of their surgery. Total arch recon-
struction (n ¼ 208) consisted of reimplantation of the great
vessels as an island (n ¼ 134), total arch or island with an
elephant trunk (n ¼ 72), and total arch replacement with
great vessel debranching (n ¼ 2). All other arch procedures
consisted of hemiarch reconstruction (n ¼ 671).
The patient demographics are listed in Table 1. The mean
age of the 879 patients was 65 13.3 years. Most were men
(539 of 879, 61%). Of the 879 patients, 51 (5.8%) had pre-
sented with aortic rupture. The total arch group had a
greater percentage of patients with known connective tissue
disorders (13 of 208, 6.3%, vs 17 of 671, 2.5%; P<.015),
and the hemiarch groups had more patients with previous
myocardial infarction (125 of 671, 18.6%, vs 23 of 208,
11%; P<.011). A significantly greater percentage of hemi-
arch operations were performed under urgent or emergency
conditions (346 of 671, 52%, vs 74 of 208, 36%;TABLE 2. Intraoperative data
Variable Hemiarch (n ¼
Cooling time (min) 34.55  5.0
Warming time (min) 72.00  15.
Circulatory arrest time (min) 21.33  6.3
RCP time (min) 19.88  6.3
Pump time (min) 145.97  33.
Total cardiac ischemic time (min) 90.76  35.
Concomitant procedures
Ascending tube graft 459 (64.8)
CVG 153 (22.8)
Aortic valve replacement 137 (20.4)
CABG 138 (20.6)
Aortic valve repair 182 (27.1)
No blood products received during surgery 334 (49.8)
Data presented as mean  standard deviation (95% confidence interval) or n (%). RCP,
bypass grafting.
The Journal of Thoracic and CarP<.0001). The hemiarch group also had nearly twice the
percentage of patients with acute type A dissection (198
of 671, 30%, vs 28 of 208, 14%; P<.001). Five patients
(5 of 671, 0.7%) in the hemiarch group presented with acute
type A dissection and rupture who were taken to the oper-
ating room with ongoing cardiopulmonary resuscitation.
All other preoperative risk factors were similar between
the 2 groups.
The intraoperative data are listed in Table 2. The patients
undergoing total arch replacement had significantly longer
mean periods of PHCA (39.92 12.14 vs 21.33 6.30 mi-
nutes; P<.0001) and RCP (36.94  10.57 vs 19.88  6.35
minutes; P < .0001) than those undergoing hemiarch
replacement. Those undergoing total arch replacement
also had longer periods of cardiac ischemia and CPB
time. The increase in these 2 parameters occurred despite
the greater number of complex aortic root reconstructions
and aortic valve replacements in the hemiarch group. No
significant difference was found in the percentage of671) Total arch (n ¼ 208) P value
0 34.64  4.38 .811
92 69.51  14.18 .044
0 39.92  12.14 .0001
5 36.94  10.57 .0001
33 158.39  34.62 .0001
87 102.70  34.03 .0001
166 (79.8) .02
33 (15.9) .033
32 (15.4) .131
39 (18.8) .621
44 (21.1) .102
105 (50.5) .874
Retrograde cerebral perfusion; CVG, composite valve graft; CABG, coronary artery
diovascular Surgery c Volume 148, Number 6 2929
TABLE 3. Perioperative morbidity and mortality
Variable
Hemiarch
(n ¼ 671)
Total arch
(n ¼ 208) P value
TND 20 (3.0) 5 (2.4) .813
PND 9 (1.34) 4 (1.9) .519
Postoperative respiratory complications .758
Prolonged intubation 22 (3.3) 6 (2.9) .99
Pneumonia 6 (0.9) 1 (0.48) .99
Reintubation 4 (0.6) 3 (1.44) .366
Tracheostomy 24 (3.6) 8 (3.8) .834
Postoperative dialysis 16 (2.4) 3 (1.44) .328
SWI 6 (2.9) 2 (0.96) .95
Re-exploration for postoperative
bleeding
29 (4.3) 11 (5.3) .569
Perioperative mortality 32 (4.8) 1 (0.48) .003
Data presented as n (%). TND, Transient neurologic deficit; PND, permanent neuro-
logic deficit; SWI, sternal wound infection.
TABLE 4. Morbidity and mortality for total arch replacement with
periods of PHCA<40 or>40 minutes
Variable
Total arch, circulatory
arrest time (min)
P value<40 (n ¼ 112) 40 (n ¼ 96)
PND 2 (1.8) 2 (2.1) .99
TND 1 (0.9) 4 (4.2) .184
Postoperative dialysis 2 (1.8) 1 (1.0) .99
Postoperative respiratory
complications
4 (3.6) 14 (14.6) .026
Intubation>48 h 1 5 .097
Pneumonia 1 0 .99
Reintubation 0 3 .097
Tracheostomy 2 6 .147
Re-exploration for postoperative
bleeding
3 (2.7) 8 (8.3) .117
Perioperative mortality 0 1 (1.0) .442
Data presented as n (%). PND, Permanent neurologic deficit; TND, transient neuro-
logic deficit.
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Dpatients in either group receiving blood transfusions in the
operating room.
The perioperative morbidity and mortality for all 879 pa-
tients are listed in Table 3. The incidence of PND (hemi-
arch, 9 of 671, 1.3%, vs total, 4 of 208, 1.9%; P<.519)
was similar in both groups despite the longer periods of
PHCA in the total arch cohort. Similar results were also
seen for TND. The need for a return to the operating
room for postoperative hemorrhage was also quite consis-
tent between the 2 groups. The perioperative mortality
was significantly greater in the hemiarch group (32 of
671, 4.8%, vs 1 of 208, 0.5%; P<.00001). No difference
was seen in the patients undergoing elective repair; howev-
er, most of the difference in mortality was seen in those pre-
senting with acute type A dissection.
The morbidity and mortality in patients undergoing total
arch replacement with PHCA times>40 or<40 minutes are
compared in Table 4. Those with times>40 minutes did not
have a greater incidence of PND (2 of 96, 2.1%, vs 2 of 112,
1.8%; P<.99) or TND (4 of 96, 4.2%, vs 1 of 112, 0.9%;
P< .18) than their counterparts with times<40 minutes.
Respiratory complications were more common in those un-
dergoing PHCA for>40 minutes (14 of 96, 14.6%, vs 4 of
112, 3.6%; P<.026). No difference was found in perioper-
ative mortality (1 of 96, 1.0%, vs 0 of 112, 0%; P<.44).
We examined the outcomes for 34 patients undergoing
total arch replacement requiring PHCA>50 minutes. The
mean PHCA time was 59 minutes (range, 51-89). These pa-
tients were younger (mean age, 59.6 years), were more
likely to be men (76.5%), and had larger aneurysms
(mean diameter, 6.63 cm). A significantly greater percent-
age had had previous open heart surgery (20 of 34, 58.8%
vs 38 of 174, 21.8%; P<.001). Most of their previous op-
erations (19 of 20, 95%) had been aortic. Despite a longer
PHCA period, no increase occurred in the incidence of PND
(1 of 34, 2.9%) or TND (1 of 34, 2.9%). Postoperative res-
piratory complications were more prominent (8 of 34,2930 The Journal of Thoracic and Cardiovascular Sur23.5%, vs 10 of 174, 5.7%; P< .007). No perioperative
deaths occurred.
The risk factors for TND, PND, and mortality were
calculated using multivariate analysis of univariate factors
with a P value<.2. A previous CVA (odds ratio [OR],
3.4; P< .006) and chronic obstructive pulmonary disease
(OR, 2.4; P<.051) were independent predictors of postop-
erative neurologic injury, but the PHCA time was not (OR,
1.0; P< .620). Female sex (OR, 6.6; P< .007), chronic
obstructive pulmonary disease (OR, 3.8; P<.029), hemi-
arch reconstruction (OR, 2.2; P<.004), PHCA time (OR,
1.1; P < .035), postoperative renal failure (OR, 15.6;
P< .0001), and postoperative PND (OR, 4.6; P< .019)
were independent predictors of perioperative mortality.
The median follow-up period for all patients was 60
months and was 92% complete. The actuarial survival of pa-
tients undergoinghemiarch repair versus total arch repair at 1,
5, and 10 years was 89%, 77%, and 65% versus 87%, 74%,
and 58%, respectively (log-rank P ¼ .38; Figure 1, A). The
actuarial survival for those with a PHCA time<40 versus
>40 minutes at 1, 5, and 10 years was 88%, 78% and 60%
versus 84%, 69% and 56%, respectively (log-rank
P¼ .28; Figure 1,B). Patientswith a PHCAtime>50minutes
also had actuarial survival similar to that of their counterparts
with a PHCA time<50 minutes (log-rank P ¼ .45).DISCUSSION
Aortic arch reconstruction remains a formidable surgical
undertaking. A myriad of pathologic entities creates com-
plex anatomy that challenges the surgeon to definitively re-
establish the circulation to the body and brain in a timely
fashion to avoid permanent end organ damage. As the sur-
gical technique, graft technology, and postoperative care
have improved, the morbidity and mortality of arch surgery
now rarely result from technical shortcomings leading togery c December 2014
FIGURE 1. A, Kaplan-Meier survival curve for patients with hemiarch and total arch replacement. B, Kaplan-Meier survival curve for patients with total
arch replacement with profound hypothermic circulatory arrest time of<40 vs>40 minutes.
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Dcatastrophic hemorrhage and massive transfusion. Re-
exploration for postoperative bleeding occurs in approxi-
mately 5% of cases in many large series, similar to the
4.5% rate seen in our cohort.4,10 When the arch
reconstruction is technically sound, profound hypothermia
will have little influence on postoperative bleeding. One
half of the patients in the present series received no blood
products during their operation. Furthermore, those
exploring ACP with moderate hypothermia have reported
similar or greater rates of postoperative hemorrhage.15-17
A contemporary series of patients undergoing arch
reconstruction at a mean temperature of approximately
25C reported a re-exploration rate of 15.3%. They still
could not demonstrate a relationship between the tempera-
ture and bleeding events, even on multivariate analysis.18
Despite this fairly high rate of re-exploration, they were
also unable to demonstrate a relationship between bleeding
and perioperative mortality, even in a propensity-matched
cohort. Anastomotic hemorrhage and the significant trans-
fusion associated with this issue is rarely coagulopathic.
Most high-volume aortic surgeons show respect for this
issue by taking the time to reinforce high-pressure suture
lines before resuming CPB. The extra time needed to
perform this lifesaving maneuver is irrelevant to either the
neurologic outcomes or mortality, as demonstrated by the
excellent results witnessed for arch surgery in the current
era. Meticulous technique remains the cornerstone of suc-
cess with arch surgery and is a far more important contrib-
utor to the outcome than hypothermia.
Temporary and permanent neurologic dysfunction after
arch surgery remains of primary concern and is highly pre-
dictive of perioperative mortality and reduced mid- and
long-term survival.16 In addition, fine neuropsychometric
testing can detect neurologic deficits that not only affect
mortality but also reduce higher cortical function for 3
months after arch reconstruction, even with periods of
PHCA of 25 minutes.19 Patient factors clearly influence
the incidence of postoperative PND and TND. Hyperten-
sion, cerebrovascular disease, glomerular filtration rateThe Journal of Thoracic and Car<90 mL/min, atherosclerotic aneurysms, and emergency
surgery status have all been associated with worse neuro-
logic outcomes, regardless of the perfusion strategy or the
addition of adjuncts for neurologic protection.10,20
Intraoperative factors such as the cannulation site, acid-
base strategy, and temperature can also contribute to a
greater rate of neurologic injury.2 We, too, found preopera-
tive comorbid conditions such as previous CVA and chronic
obstructive pulmonary disease highly predictive of neuro-
logic injury after arch repair. No doubt exists that patients
undergoing such surgery are a relatively high-risk cohort
of patients. Compared with their counterparts undergoing
coronary artery bypass grafting, the greater incidence of
persistent neurocognitive deficits was not surprising.21
Many of these factors are not alterable. However, contro-
versy is ongoing about the efficacy of PHCA, RCP, and
ACP in preventing stroke, mortality, and neurocognitive
deficits.11,14,16,22 This controversy is even more pertinent
when examining a cohort of patients receiving longer
periods of PHCA with an arrest time>40 minutes were
found to correlate strongly with persistent neurocognitive
dysfunction on fine neuropsychometric testing.23 Although
many of these finer deficits are clinically undetectable,
many more patients coming for surgery have complex
arch pathologic features that mandate longer CPB times,
cardiac ischemia, and PHCA. It is relevant to examine the
outcomes of these patients with advanced disease to opti-
mize a neuroprotective strategy. We believe that the data
we have presented support the use of RCP in complex
arch surgery with a substantial percentage of patients hav-
ing excellent clinical outcomes.
In our experience, RCP provided equivalent neurologic
protection in patients undergoing both simple hemiarch
and complex total arch surgery. The risk of PND was
1.9% in the 208 patients who underwent total arch recon-
struction, not significantly different (P < .52) from the
1.3% rate in the 671 patients who had undergone hemiarch
repair. Similarities were also seen in both groups with
respect to TND, with neither group experiencing thediovascular Surgery c Volume 148, Number 6 2931
Acquired Cardiovascular Disease Girardi et al
A
C
Dcomplication>3% of the time. Even in the nearly 100 pa-
tients requiring>40 minutes of PHCA to complete the pro-
cedure, permanent neurologic injury occurred at a rate of
2.1%. A small increase was seen in the rate of TND in
this>40-minute group (4.2%), but the difference was not
statistically significant. We did not see an increase in the
risk of PND or TND in a smaller cohort of patients requiring
very extensive periods of circulatory arrest. In those 34 pa-
tients, the incidence of both complications was 2.9%,
despite a mean PHCA time of 59 minutes (range, 51-87).
The mortality in this select group was 0. These results sup-
port those from Estrera and colleagues,20 who reported a
PND rate of 2.8% in 1107 patients who had undergone
arch reconstruction with PHCA and RCP as their strategy
of brain protection. Okita and colleagues24 reported on their
experience in a small group of patients also undergoing arch
reconstruction with prolonged periods of circulatory arrest
(mean time, 60 minutes). Although their rate of PND
(4%) was similar to ours and those from other contempo-
rary reports, their 25% incidence of TND was disap-
pointing. However, nearly one third of their cohort
underwent arch reconstruction through a left posterolateral
thoracotomy. Delivery of RCP by way of the left chest is
less certain, limiting the efficacy of RCP to reliably flush
debris and air out of the cerebral circulation.24 Although
the University of Pennsylvania group did not report the
risk of neurologic injury in their cohort of patients with
PHCA lasting>45 minutes, they, too, reported PND and
TND rates of 2.8% and 3.7%, respectively, in 682 patients
who underwent arch reconstruction with the assistance of
RCP.10
Our results with RCP also compared favorably with those
published recently from a large meta-analysis comparing
RCP and ACP.14 In that study, Hu and colleagues,14 re-
ported the incidence of CVA in 5060 patients undergoing
arch surgery. Patients receiving RCP as their primary
adjunct for neurologic protection had a significantly lower
risk of postoperative CVA compared with those who
received ACP (4.7% vs 7.2%, P<.01). Modifications in
the delivery of ACP did not seem to diminish the risk of
PND further. Angeloni and colleagues22 compared bilateral
and unilateral ACP in a meta-analysis of 5100 patients. The
risk of PND was 6.1% with unilateral perfusion and did not
decline significantly (6.5%, P¼ .8) when ACP was admin-
istered to both hemispheres. Despite continuous perfusion
of both carotid circulations, the risk of TND also did not
decline (7.1% unilateral vs 8.8% bilateral; P ¼ .46).
Although antegrade perfusion of the brain with ACP clearly
provides nutritive brain flow, it is difficult to negate the po-
tential for embolic phenomenon created by clamping and
manipulating the great vessels.22 Although the mechanism
of protection with RCP is not completely understood, it is
believed that its primary mechanism of neurologic protec-
tion is the flushing of atheromatous debris from the cerebral2932 The Journal of Thoracic and Cardiovascular Surcirculation.20 Although some concerns have been raised for
the potential for cerebral edema with RCP,25 power
M-mode transcranial Doppler observation of the cerebral
circulation during RCP failed to detect differences in the
pulsatility index or end-diastolic flow velocities to support
this concern.26 Whether RCP flushes toxic byproducts of
metabolism out of the brain is still debated but could also
prove important in explaining the efficacy of this technique.
Regardless of the mechanism of action, RCP minimized
the risk of temporary and permanent neurologic injury in
our patients undergoing arch reconstruction. These data
reinforce the importance of PND and TND as markers of
greater perioperative mortality. A postoperative CVA in
our experience significantly increased the risk of death
(OR, 4.6; P< .019). Misfeld and colleagues16 also high-
lighted the importance of PND to mid-term survival. Those
experiencing a neurologic injury during arch surgery had a
<50% 3-year actuarial survival and those without a neuro-
logic event had a 3-year survival rate of>80% (log-rank
P<.001).
The present study had limitations that should be
considered. The present study was a retrospective, single-
institution, and single-surgeon experience. The extrapola-
tion of our data to a more heterogeneous population of
patients and surgeons might not be applicable. The results
could also have been influenced by the much greater per-
centage of patients undergoing hemiarch repair instead of
total arch repair. We performed propensity matching to
eliminate the bias presented by such disparate numbers.
We identified 55 patients who were appropriately matched.
We did not find a significant difference in the outcomes be-
tween the 2 groups. Finally, we did not perform advanced
neuropsychometric testing on our subjects either before or
after surgery. Clearly, such testing is a more sensitive indi-
cator of neurologic injury than clinical observation. Wewill
investigate the potential for this type of study for future
patients undergoing arch reconstruction.
CONCLUSIONS
RCP is a safe and effective adjunct to profound hypother-
mia for neuroprotection and mortality reduction in patients
undergoing aortic arch reconstruction. Additional investi-
gation into its elusive mechanism of action is warranted;
however, the avoidance of great vessel manipulation and
embolic phenomena is quite advantageous, especially in a
population with advanced atherosclerotic disease.
References
1. Griepp RB, Stinson EB, Hollingsworth JF, Buehler D. Prosthetic replacement of
the aortic arch. J Thorac Cardiovasc Surg. 1975;70:1051-63.
2. Svensson LG, Crawford ES, Hess KR, Coselli JS, Raskin S, Shenaq SA, et al.
Deep hypothermia with circulatory arrest: determinants of stroke and early
mortality in 656 patients. J Thorac Cardiovasc Surg. 1993;106:19-28; discussion
28-31.
3. Griepp RB. Cerebral protection during aortic arch surgery. J Thorac Cardiovasc
Surg. 2001;121:425-7.gery c December 2014
Girardi et al Acquired Cardiovascular Disease
A
C
D4. Gega A, Rizzo JA, Johnson MH, Tranquilli M, Farkas EA, Elefteriades JA.
Straight deep hypothermic arrest: experience in 394 patients supports its effec-
tiveness as a sole means of brain preservation. Ann Thorac Surg. 2007;84:
759-66; discussion 766-7.
5. Dewhurst AT, Moore SJ, Liban JB. Pharmacological agents as cerebral protec-
tants during deep hypothermic circulatory arrest in adult thoracic aortic surgery:
a survey of current practice. Anaesthesia. 2002;57:1016-21.
6. Shum-Tim D, Tchervenkov CI, Jamal AM, Nimeh T, Luo CY, Chedrawy E, et al.
Systemic steroid pretreatment improves cerebral protection after circulatory ar-
rest. Ann Thorac Surg. 2001;72:1465-71; discussion 1471-2.
7. Ueda Y, Okita Y, Aomi S, Koyanagi H, Takamoto S. Retrograde cerebral perfu-
sion for aortic arch surgery: analysis of risk factors. Ann Thorac Surg. 1999;67:
1879-82; discussion 1891-4.
8. Ehrlich MP, Hagl C, McCullough JN, Zhang N, Shiang H, Bodian C, et al. Retro-
grade cerebral perfusion provides negligible flow through brain capillaries in the
pig. J Thorac Cardiovasc Surg. 2001;122:331-8.
9. Boeckxstaens CJ, Flameng WJ. Retrograde cerebral perfusion does not perfuse
the brain in nonhuman primates. Ann Thorac Surg. 1995;60:319-27; discussion
327-8.
10. Milewski RK, Pacini D, Moser GW, Moeller P, Cowie D, Szeto WY, et al. Retro-
grade and antegrade cerebral perfusion: results in short elective arch reconstruc-
tive times. Ann Thorac Surg. 2010;89:1448-57.
11. Okita Y, Minatoya K, Tagusari O, Ando M, Nagatsuka K, Kitamura S. Prospec-
tive comparative study of brain protection in total aortic arch replacement: deep
hypothermic circulatory arrest with retrograde cerebral perfusion or selective an-
tegrade cerebral perfusion. Ann Thorac Surg. 2001;72:72-9.
12. Urbanski PP, Lenos A, Bougioukakis P, Neophytou I, Zacher M, Diegeler A.
Mild-to-moderate hypothermia in aortic arch surgery using circulatory arrest: a
change of paradigm? Eur J Cardiothorac Surg. 2012;41:185-91.
13. Salazar J, Coleman R, Griffith S, McNeil J, Young H, Calhoon J, et al. Brain pres-
ervation with selective cerebral perfusion for operations requiring circulatory ar-
rest: protection at 25C is similar to 18C with shorter operating times. Eur J
Cardiothorac Surg. 2009;36:524-31.
14. Hu Z, Wang Z, Ren Z, Wu H, Zhang M, Zhang H, et al. Similar cerebral protec-
tive effectiveness of antegrade and retrograde cerebral perfusion combined with
deep hypothermia circulatory arrest in aortic arch surgery: a meta-analysis and
systematic review of 5060 patients. J Thorac Cardiovasc Surg. 2014;148:544-60.
15. Tsai JY, Pan W, LeMaire SA, Pisklak P, Lee VV, Bracey AW, et al. Moderate hy-
pothermia during aortic arch surgery is associated with reduced risk of early mor-
tality. J Thorac Cardiovasc Surg. 2013;146:662-7.
16. Misfeld M, Leontyev S, Borger MA, Gindensperger O, Lehmann S, Legare JF,
et al. What is the best strategy for brain protection in patients undergoing aortic
arch surgery? A single center experience with 636 patients. Ann Thorac Surg.
2012;93:1502-9.
17. Sundt TM III, Orszulak TA, Cook DJ, Schaff HV. Improving results of open arch
replacement. Ann Thorac Surg. 2008;86:787-96.
18. Kamiya H, Hagl C, Kropivnitskaya I, B€othig D, Kallenbach K, Khaladj N, et al.
The safety of moderate hypothermic lower body circulatory arrest with selective
cerebral perfusion: a propensity score analysis. J Thorac Cardiovasc Surg. 2007;
133:501-9.
19. Harrington DK, Bonser M, Moss A, Heafield MT, Riddoch MJ, Bonser RS. Neu-
ropsychometric outcome following aortic arch surgery: a prospective random-
ized trial of retrograde cerebral perfusion. J Thorac Cardiovasc Surg. 2003;
126:638-44.
20. Estrera AL, Miller CC III, Lee TY, Shah P, Safi HJ. Ascending and transverse
aortic arch repair: the impact of retrograde cerebral perfusion. Circulation.
2008;118(Suppl):160-6.
21. Newman M, Kirchner J, Phillips-Bute B, Gaver V, Grocott H, Jones RH, et al.
Longitudinal assessment of neurocognitive function after coronary-artery bypass
surgery. N Engl J Med. 2001;344:395-402.
22. Angeloni E, Benedetto U, Takkenberg JJM, Stigliano I, Roscitano A, Melina G,
et al. Unilateral versus bilateral antegrade cerebral perfusion during circulatory
arrest in aortic surgery: a meta-analysis of 5100 patients. J Thorac Cardiovasc
Surg. 2014;147:60-7.
23. Chau KH, Friedman T, Tranquilli M, Elefteriades JA. Deep hypothermic circu-
latory arrest effectively preserves neurocognitive function. Ann Thorac Surg.
2013;96:1553-9.
24. Okita Y, Takamoto S, AndoM,Morota T,Matsukawa R, Kawashima Y.Mortality
and cerebral outcome in patients who underwent aortic arch operations using
deep hypothermic circulatory arrest with retrograde cerebral perfusion: no rela-The Journal of Thoracic and Cartion of early death, stroke and delirium to the duration of circulatory arrest. J
Thorac Cardiovasc Surg. 1998;115:129-38.
25. Reich DL, Uysal S, Sliwinski M, ErginMA, Kahn RA, Konstadt SN, et al. Neuro-
psychologic outcome after deep hypothermic circulatory arrest in adults. J
Thorac Cardiovasc Surg. 1999;117:156-63.
26. Estrera AL, Garami Z, Miller CC III, Sheinbaum R, Huynh TT, Porat EE, et al.
Determination of cerebral blood flow dynamics during retrograde cerebral perfu-
sion using power M-mode transcranial Doppler. Ann Thorac Surg. 2003;76:
704-10.Discussion
Dr Anthony L. Estrera (Houston, Tex). I have nothing to
disclose.
Since Dr Griepp’s seminal report on the use of PHCA for total
arch replacement, many adjuncts have been devised for use in
combination for cerebral protection. Ueda with RCP and Bachet
and Kazui with ACP were early proponents.
Currently, most large aortic centers have reported the use of
ACP as the primary mode of cerebral perfusion during hypother-
mic circulatory arrest, suggesting that the use of RCP has for the
most part been abandoned.
The findings from the present report by Girardi and colleagues,
in which RCP was used as the primary adjunct for cerebral perfu-
sion during ascending and arch replacement, resulting in very envi-
able outcomes, stroke of 2%, mortality of 4%, including those with
type A dissection, suggest that RCP could still play a pertinent
role.
Despite my enthusiasm for RCP during circulatory arrest, I
must be candid and discerning of this report by Girardi and col-
leagues. As acknowledged by the authors, the study was a retro-
spective analysis with its inherent limitations, occurring during a
15-year period and, thus, potentially biased by the changes that
could have occurred over time.
The study design was more observational than comparative,
because no true control group was designated. Because it was a
single-center and single-surgeon study, the results should not
necessarily be generalized. Despite these issues, it was a very large
series that provides value in the questions that arise from such a
study.
I have a few questions that can be answered consecutively.
First, the atheromatous burden remains a significant risk factor
for stroke after cardiovascular surgery. Do you have any informa-
tion on the degree of aortic atheromatous disease, and can you
please comment on your interrogation methods before cannulating
the ascending aorta?
Dr Girardi. Yes, and thank you very much, Dr Estrera.
So, before surgery, all our patients underwent transesophageal
echocardiography. In those patients who were deemed to have
grade 4 or 5 disease, we then tried to use epiaortic scanning. We
also used epiaortic echocardiography if we had found palpably sig-
nificant calcium in the ascending aorta or arch in the area in which
we were anticipating cannulation.
Also, in those patients with a very hostile ascending aorta, we
will switch to femoral access, which does not adversely affect
our stroke risk. Obviously, computed tomography or magnetic
resonance imaging will provide us with some idea of what is pre-
sent in the descending aorta, and we can also see that with trans-
esophageal echocardiography.diovascular Surgery c Volume 148, Number 6 2933
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perature management during repair? How was your temperature
measured? What determined how long you cool? I noticed it
was about 33 minutes as the mean cooling time.
Dr Girardi. We have avoided electroencephalographic moni-
toring while cooling. It was just a logistical problem for us. We
used it early in our experience and found that if wewent to electroen-
cephalographic silence, it did not necessarily eliminate ourneurologic
problems, especially with TND. Not so much permanent deficits, but
TND was still a problem if we cooled for<25 minutes or so.
We set a minimum of 30 minutes as our mark. We used the
bladder temperature as our cooling monitor. If the patient was
anuric from end-stage renal disease, we used a tympanic probe.
We have not found anything else to be terribly reliable.
Dr Estrera. Third, please elaborate on your neuromonitoring
approach. Do the near-infrared spectroscopy (NIRS) findings
change what you do? Do you modify your RCP perfusion pres-
sures during circulatory arrest if you do see changes?
Dr Girardi. Yes. We have used NIRS mostly to monitor perfu-
sion when we return to CPB. For the patients with acute type A
dissection, we use it when we first start CPB, because certainly ce-
rebral malperfusion can happen when you are using femoral can-
nulation. We have seen it once or twice, and that has, on an
emergency basis, changed our method of perfusion.
We also use it when we return to CPB after circulatory arrest,
because we want to ensure that we have been perfusing both hemi-
spheres equally. Also, I think it is very sensitive for showing that.
Regarding the trends with the patient under circulatory arrest,
we have seen most of the time that the NIRS is around 60 or 70.
Occasionally, after 40, 50minutes, it might decrease 5 or 10 points,
but not more than that.
When you consider the general population of patients undergo-
ing CPB, NIRSmonitoring is not particularly sensitive at detecting
a real problem until the finding is less than about 30%, which we
rarely, if ever, see.
Dr Estrera. Finally, as many would have me believe, is RCP
dead?
Dr Girardi. I do not think RCP is dead, and I know a few of us
out there are still using it. I understand the concerns for it, but I
think, as you can see fromDr Elefteriades’ presentation, I think hy-
pothermia is the key element of brain protection. Whether you add
on RCP or ACP in addition to cold or just use straight profound hy-
pothermia, I think you achieve pretty good protection, particularly
with short periods of circulatory arrest.
Also, I think what we are all looking for is what to do with these
really complex patients out in that 50- to 60-minute range. Our
data would suggest that RCP is safe in that patient population.
Of course, as you noted the limitations of the study, it was retro-
spective and a single-institution, single-surgeon experience.
However, for the overwhelming majority undergoing arch sur-
gery, I think RCP works pretty well.
Dr Yutaka Okita (Kobe, Japan). Recently, we collected Japa-
nese data for 4 years, 8000 cases of total arch replacement, and
1000 received RCP and 7000, ACP.
Virtually RCP people tend to do arch first techniques. It is very
short even in total arch replacements.
We found virtually no difference in stroke, TND, or early mortal-
ity. However, we found the RCP patients tended to wake up late and2934 The Journal of Thoracic and Cardiovascular Surstay in the intensive care unit longer.Also,ACPpatientsusuallywoke
upon thedayof the operation.TheRCPpatientswokeup thenext day
and they extubated late. Did you consider this wake-up time?
DrGirardi.Wedid not study thewake-up time per se; however,
our transient neurologic deficit rate included those patients who
had temporary defects that did not allow them to wake up imme-
diately. Again, confusion, delirium, items along those lines, are
difficult to quantify; however, we included all those into our
TND experience.
The experience in 2 large meta-analyses with>5000 patients in
each study showed very little difference between the results with
the ACP or RCP. However, meta-analyses have a number of limi-
tations and the data have not convinced me regarding the safety of
ACP, either unilateral or bilateral, compared with RCP.
Dr Joseph S. Coselli (Houston, Tex).Len, I am going to jump in
with 1 quick question. Returning even to the experience that you
referenced with Dr Crawford, when we used a very similar tech-
nique to what you described, we encountered a peculiar phenom-
enon frequently referred to as ‘‘supranuclear hemianopsia,’’ which
manifested primarily by a disconjugate gaze. However, in the
many hundreds of cases, since we have switched to ACP, although
it is a rare complication, we just have not seen it anymore. You
have a very, very large series. Any experience with that?
Dr Girardi. Thank you Joe. I am familiar with that problem but
we did not see that at all, not 1 time.
Dr John A. Elefteriades (New Haven, Conn). First, congratu-
lations on the fantastic results and a beautiful report.
My short question is, is it possible that the RCP is ‘‘just along
for the ride’’?
Dr Girardi. It is possible. I think, just as your group has so
eloquently shown, 40 minutes with straight hypothermic arrest,
things are pretty safe.
I agree with your group that profound hypothermia is the key.
Cold has gotten a really bad reputation as you can see with some
of the ACP reports that are now espousing moderate hypothermia.
Forgive me, I know Dr Coselli’s group recently published on this
and showed very good results withmoderate hypothermia. Howev-
er, I have a number of concerns about that technique, not only for
brain protection, but also for end organ protection, including the
kidneys, spinal cord, and gut.
Also, I realize that a number of centers using it on a regular basis
have become pretty comfortablewith it. However, I do not think that
profound hypothermia carries with it the bleeding risks that con-
cerned surgeons in the past. I think if you really take the time to rein-
force your suture lines and achieve surgical hemostasis before
returning the patient to CPB, bleeding will not be a great risk.
So, I like cold. We like cold. Also, I think up to about 40 mi-
nutes, the use of adjunct therapy might not add a lot.
Dr Eric E. Roselli (Cleveland, Ohio). Len, I echo the congrat-
ulations from everyone else. Outstanding acute results.
These patients who have disease encroaching on their arch or
involving their arch obviously have an entire aorta that is diseased,
and what I am concerned about is that at 10 years, we only saw sur-
vival of around 60%.
Can you tell us whether you have any information about the
modes of death of these patients, and tell us what you do to
follow-up these patients. Do you continue to monitor them long
term with imaging of their aortas?gery c December 2014
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follow-up patients with imaging for as long as they will continue
to come for their imaging studies or go to their local place for im-
aging studies and send them to us.
For those patients for whom we were unable to get
adequate follow-up data at our institution, we would call
the referring physicians, the family, and the Social SecurityThe Journal of Thoracic and CarDeath Index to confirm death. However, we were unable to
determine the modes of death exactly for many of these
patients.
Regarding the need for reintervention on our arch patients, we
had a very low rate of reintervention. It was somewhat<5% out
to 5 to 7 years. We have not published those data yet, but we are
compiling the data.diovascular Surgery c Volume 148, Number 6 2935
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